Acuta Capital Partners

Acuta Capital Partners

Be the first to review

Independent rating of Acuta Capital Partners VC fund

Overall rating:
Not reviewed

About Acuta Capital Partners VC fund

Number of investments:
10
Number of exits:
6
Organization type:
Venture Capital

How Acuta Capital Partners VC fund invests

Rounds:
Series B, Series C, Post, Venture Round
Average ticket size:
29.3M USD
Smallest investment:
7.46M USD
Biggest investment:
43.4M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States, Ireland
Sectors of interest:
Biotechnology, Health Care, Therapeutics, Pharmaceutical, Biopharma, Medical Device, Medical, Manufacturing, Life Science

Portfolio - latest investments by Acuta Capital Partners VC fund
Locanabio
Flame Biosciences
Kadmon
ViewRay
Vividion Therapeutics
Pyxis Oncology
Cyteir Therapeutics
RayzeBio
GH Research
Artiva Biotherapeutics

Founders' reviews of Acuta Capital Partners VC fund

Be the first one to review Acuta Capital Partners.
Nobody reviews Acuta Capital Partners just yet. Help other founders navigate by writing about your experience with them.
Similar funds